People: Acorda Therapeutics Inc (ACOR.O)
28 Aug 2015
Mr. Michael W. Rogers is a Chief Financial Officer of Acorda Therapeutics, Inc. Mr. Rogers joins Acorda with 22 years of experience in the biopharmaceutical industry. Most recently, he served as Executive Vice President and CFO of BG Medicine, Inc., where he led the company's successful initial public offering (IPO) in 2011 and was instrumental in assisting in the launch of that company's first product in the cardiovascular area. Prior to that, Mr. Rogers served as the CFO of Indevus Pharmaceuticals for 10 years until the company's sale to Endo Pharmaceuticals. He has led multiple private and public financings and had a central role in numerous mergers and acquisitions over the course of his career, which includes both in-house leadership positions and serving as an external financial advisor.
|Total Annual Compensation, USD||649,584|
|Restricted Stock Awards, USD||72,262|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||573,220|
|Fiscal Year Total, USD||1,295,070|